Admin Login      My Saved Results      Contact Us      News & Events FaceBook Twitter YouTube LinkedIn

Lewis Hall Singletary Oncology Center at John D. Archbold Memorial Hospital

printPrint Results Email Results Save Results
Archbold Medical Center is accredited by the Commission on Cancer of the American College of Surgeons as a Community Hospital Comprehensive Cancer Program. The center participates in clinical trials involving new therapies and diagnostics. The Lewis Hall Singletary Oncology Center is a member of the Georgia CORE Research Network, a statewide network of academic and community-based oncologists and researchers. The Lewis Hall Singletary Oncology Center, located in Thomasville, Georgia, has served patients from over 45 different counties in Georgia, Florida and Alabama. The cancer center has five medical oncologists and two radiation oncologists. The Lewis Hall Singletary Oncology Center is home to technology and amenities not commonly seen in the region, such as private infusion rooms, the Gamma Knife – non-invasive precision radiosurgery – and a breast cancer patient navigator program.

Treatment Sites in Georgia

Primary Location

919 South Broad Street
Thomasville, GA 31792
229-584-5468 (p)
229-551-8647 (f)
www.archbold.org

driving directions

Archbold Specialty Clinic

1323 E. Shotwell St
Bainbridge, 39819
229-4939968 (p)
229-493-9983 (f)


driving directions

Camilla Clinic

259 US Hwy 19
Camilla, 31730


driving directions

Clinical Trials in Georgia

A Phase 2 Study of IPI-145 in Subjects With Refractory Indolent Non-Hodgkin Lymphoma
Cancer Type: Lymphoma
Study Coordinator: Colette Hilliard, MS, CCRC - 229-584-5468


A Phase IIIb/IV Safety Trial of Nivolumab (BMS-936558) in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Progressed During or After Receiving At Least One Prior Systemic Regimen
Cancer Type: Lung Cancer
Study Coordinator: Colette Hilliard, MS, CCRC - 229-584-5468


A Randomized Double-blind, Placebo-controlled Study of LEE011 in Combination With Letrozole for the Treatment of Postmenopausal Women With Hormone Receptor Positive, HER2 Negative, Advanced Breast Cancer Who Received no Prior Therapy for Advanced Disease
Cancer Type: Breast Cancer
Study Coordinator: Colette Hilliard, MS, CCRC - 229-584-5468


A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Long-term Safety and Efficacy of Darbepoetin Alfa Administered at 500 µg Once-Every-3-Weeks in Anemic Subjects With Advanced Stage Non-small Cell Lung Cancer Receiving Multi-cycle Chemot
Cancer Type: Lung Cancer
Study Coordinator: Colette Hilliard, MS, CCRC - 229-584-5468


A Registry of Caris Target Now Test Results (Biomarker Expression Patterns) for Evaluation of Correlation with Clinical Outcomes for Cancer
Cancer Type: Multiple Primaries
Study Coordinator: Colette Hilliard, MS, CCRC - 229-584-5468


A Registry of Cesium-131 Brachytherapy Plus Sub- lobar Resection for Early Stage Lung Cancer
Cancer Type: Lung Cancer
Study Coordinator: Colette Hilliard, MS, CCRC - 229-584-5468


Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim
Cancer Type: Breast Cancer
Study Coordinator: Colette Hilliard, MS, CCRC - 229-584-5468


Studying Interventions for Managing Patients With Chronic Myeloid Leukemia (CML) in Chronic Phase: The 5-Year Prospective Cohort Study (SIMPLICITY)
Cancer Type: Leukemia
Study Coordinator: Colette Hilliard, MS, CCRC - 229-584-5468